Age- and sex-specific rates of leukoaraiosis in TIA and stroke patients population-based study

Neurology

Volumn 79, Issue 12, 2012, Pages 1215-1222

  Simoni, Michela ^a   Li, Linxin ^a   Paul, Nicola L M ^a   Gruter, Basil E ^a   Schulz, Ursula G ^a   Küker, Wilhelm ^a   Rothwell, Peter M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; GENETIC HETEROGENEITY; HUMAN; LEUKOARAIOSIS; META ANALYSIS; MORTALITY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETINA ARTERY OCCLUSION; SEX DIFFERENCE; SUBARACHNOID HEMORRHAGE; SYSTEMATIC REVIEW; TRANSIENT ISCHEMIC ATTACK; WHITE MATTER;

EID: 84867501408     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31826b951e     Document Type: Article

References (30)

1. Rothwell PM, Coull AJ, Silver LE, et al, for the Oxford Vascular Study. Population-based study of event-rate, incidence, case fatality, and mortality for all vascular events in all arterial territories (Oxford Vascular Study). Lancet 2005;366:1773-1783.
2. Towfighi A, Zheng L, Ovbiagele B. Sex-specific trends in midlife coronary heart disease risk and prevalence. Arch Intern Med 2009;169:1762-1766.
3. Marquardt L, Fairhead JF, Rothwell PM. Lower rates of intervention for symptomatic carotid stenosis in women than in men reflect differences in disease incidence: A population-based study. Stroke 2010;41:16-20.
4. Rothwell PM, Coull AJ, Giles MF, et al. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK, from 1981 to 2004 (Oxford Vascular Study). Lancet 2004;363:1925-1933.
5. Rexrode KM. Emerging risk factors in women. Stroke 2010;41(suppl 1):S9 -S11.
6. Seshadri S, Beiser A, Kelly-Hayes M, et al. The lifetime risk of stroke: Estimates from the Framingham Study. Stroke 2006;37:345-350.
7. Appelros P, Stegmayr B, Terent A. Sex differences in stroke epidemiology: A systematic review. Stroke 2009;40: 1082-1090.
8. Eriksson M, Glader E-L, Norrving B, Terent A, Stegmayr B. Sex differences in stroke care outcome in the Swedish national quality register for stroke care. Stroke 2009;40: 909-914.
9. Breteler MMB, van Swieten JC, Bots ML, et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: The Rotterdam Study. Stroke 1994;25:1109-1115.
10. Henon H, Godefroy O, Lucas Ch, Pruvo JP, Leys D. Risk factors and leukoaraiosis in stroke patients. Acta Neurol Scand 1996;94:137-144.
11. Longstreth WT Jr. Brain abnormalities in the elderly: Frequency and predictors in the United States (The Cardiovascular Health Study). J Neural Transm 1998;53(suppl): 9-16.
12. De Leeuw FE, de Groot JC, Achten E. Prevalence of cerebral white matter lesions in elderly people: A population based magnetic resonance imaging study: The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry 2001;170: 9-14.
13. Van den Heuvel DMJ, Admiraal-Behloul F, ten Dam VH, et al, for the PROSPER study group. Different progression rates for deep white matter hyperintensities in elderly men and women. Neurology 2004;63:1699-1701.
14. van Dijk EJ, Prins ND, Vrooman HA, Hofman A, Koudstaal PJ, Breteler MMB. Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences. Stroke 2008;39:2712-2719.
15. Streifler JY, Eliasziw M, Benavente OR, et al, for the North American Symptomatic Carotid Endarterectomy Trial Group. Development and progression of leukoaraiosis in patients with brain ischemia and carotid artery disease. Stroke 2003;33:1913-1917.
16. Hijdra A, Verbeeten B, Verhulst JAPM. Relation of leukoaraiosis to lesion type in stroke patients. Stroke 1990;21: 890-894.
17. Pantoni L, Basile AM, Pracucci G, et al. Impact of agerelated cerebral white matter changes on the transition to disability: The LADIS study: Rationale, design and methodology. Neuroepidemiology 2005;24:51-62.
18. Wahlund LO, Barkhof F, Fazekas F, et al, on behalf of the European Task-Force on Age-Related White Matter Changes. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 2001;32: 1318-1322.
19. Blennow K, Wallin A, Uhlemann C, Gottfries CG. White matter lesions on CT in Alzheimer patients: Relation to clinical symptomatologic and vascular factors. Acta Neurol Scand 1991;83:187-193.
20. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987; 149:351-356.
21. Landis JR, Koch GG. An application of hierarchical kappatype statistics in the assessment of majority agreement among multiple observers. Biometrics 1977;33:363-374.
22. Ikram MA, Vernooij MW, Vrooman HA, Hofman A, Breteler MMB. Brain tissue volumes and small vessel disease in relation to the risk of mortality. Neurobiol Aging 2009;30:450-456.
23. Debette S, Beiser A, DeCarli C, et al. Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia and mortality: The Framingham Offspring Study. Stroke 2010;41:600-606.
24. Fu JH, Lu CZ, Hong Z, Dong Q, Luo Y, Wong KS. Extent of white matter lesions is related to acute subcortical infarcts and predicts further stroke risk in patients with first ever ischaemic stroke. J Neurol Neurosurg Psychiatry 2005;76:793-796.
25. Miyao S, Takano A, Teramoto J, Takahashi A. Leukoaraiosis in relation to prognosis in patients with lacunar infarction. Stroke 1992;23:1434-1438.
26. Kapeller P, Barber R, Vermeulen RJ, et al, for the European Task-Force on Age-Related White Matter Changes. Visual rating of age-related white matter changes on magnetic resonance imaging: Scale comparison, interrater agreement, and correlations with quantitative measurements. Stroke 2003;34:441-445.
27. Scheltens P, Erkinjuntti T, Leys D, et al, on behalf of the European Task-Force on Age-Related White Matter Changes. White matter changes on CT and MRI: An overview of visual rating scales. Eur Neurol 1998;39:80-89.
28. Lopez OL, Becker JT, Jungreis CA, et al. Computed tomography- but not magnetic resonance imaging-identified periventricular white-matter lesions predict symptomatic cerebrovascular disease in probable Alzheimers disease. Arch Neurol 1995;52:659-664.
29. Rossi R, Joachim C, Geroldi C, et al. Association between subcortical vascular disease on CT and neuropathological findings. Int J Geriatr Psychiatry 2004;19:690-695.
30. Rossi R, Joachim C, Geroldi C, Esiri MM, Smith AD, Frisoni GB. Pathological validation of a CT-based scale for subcortical vascular disease. Dement Geriatr Cogn Disord 2005;19:61-66.